Our laboratory has previously shown that Runx1 depletion in breast cancer cells results in a decreased migration and invasion phenotype (Browne et al., 2015); similar results were found in ovarian cancer cells (Keita et al., 2013). Here, RUNX1 is linked to breast cancer.